Search Results - "Cui, Yunfu"

Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294 by Xu, Yi, Yao, Yue, Gao, Ping, Cui, Yunfu

“…Accumulating evidence indicated that dysregulated circular RNAs (circRNAs) could play pivotal roles in cancer biology. A recent study demonstrated that…”
Get full text

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway by Ma, Yanfei, Qin, Huadong, Cui, Yunfu

“…•MiR-34a is up- and GAS1 is down-regulated in papillary thyroid carcinoma.•GAS1 is a direct target for miR-34a.•MiR-34a promotes PTC cells proliferation and…”
Get full text

Bim’s Effect on the Expression of miR-423-3p in Promoting Primary Hepatic Cancer (PHC) and Role of miR-423-3p in PHC Proliferation and Invasion by Liu, Zhiqiang, Cui, Yunfu

“…In this study, we analyzed the miR-423-3p expression in primary hepatic cancer (PHC), its effect on cell proliferation, and migration and explored…”
Get full text

Long non-coding RNA MIAT in development and disease: a new player in an old game by Sun, Cheng, Huang, Lining, Li, Zhenglong, Leng, Kaiming, Xu, Yi, Jiang, Xingming, Cui, Yunfu

“…Long non-coding RNAs (lncRNAs), which are a portion of non-protein-coding RNAs (ncRNAs), have manifested a paramount role in the pathophysiology of human…”
Get full text

Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway by Xu, Yi, Yao, Yue, Leng, Kaiming, Ji, Daolin, Qu, Lijun, Liu, Yueping, Cui, Yunfu

“…Background/Aims: Circular RNAs (circRNAs) are a class of non-coding RNAs. They have been proved to be critically involved in tumorigenesis and progression of…”
Get full text

SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma by Xu, Yi, Yao, Yue, Jiang, Xingming, Zhong, Xiangyu, Wang, Zhidong, Li, Chunlong, Kang, Pengcheng, Leng, Kaiming, Ji, Daolin, Li, Zhenglong, Huang, Lining, Qin, Wei, Cui, Yunfu

“…Accumulating evidence has indicated that long non-coding RNAs (lncRNAs) behave as a novel class of transcription products during multiple cancer processes…”
Get full text

Reprogramming of central carbon metabolism in hepatocellular carcinoma by Xia, Haoming, Huang, Ziyue, Xu, Yi, Yam, Judy Wai Ping, Cui, Yunfu

“…In multicellular organisms, nutrient uptake and its metabolism are subject to stringent regulation to maintain cellular integrity and prevent aberrant cell…”
Get full text

Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer by Yu, Liang, He, Risheng, Cui, Yunfu

“…Immunotherapy has been a key option for the treatment of many types of cancer. A positive response to immunotherapy is heavily dependent on tumor…”
Get full text

The Wnt signaling pathway in hepatocellular carcinoma: Regulatory mechanisms and therapeutic prospects by Ma, Shihui, Meng, Guorui, Liu, Tong, You, Junqi, He, Risheng, Zhao, Xudong, Cui, Yunfu

“…Hepatocellular carcinoma (HCC) is a malignant tumor that arises from hepatocytes. Multiple signaling pathways play a regulatory role in the occurrence and…”
Get full text

Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease by He, Risheng, Guan, Canghai, Zhao, Xudong, Yu, Liang, Cui, Yunfu

“…Non-alcoholic fatty liver disease (NAFLD), which includes simple steatosis (SS) and non-alcoholic steatohepatitis (NASH), is a significant contributor to liver…”
Get full text

Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy by Zou, Xinlei, Guan, Canghai, Gao, Jianjun, Shi, Wujiang, Cui, Yunfu, Zhong, Xiangyu

“…Pancreatic cancer (PC) is extremely malignant and shows limited response to available immunotherapies due to the hypoxic and immunosuppressive nature of its…”
Get full text

Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway by Leng, Kaiming, Xu, Yi, Kang, Pengcheng, Qin, Wei, Cai, Hailong, Wang, Hao, Ji, Daolin, Jiang, Xingming, Li, Jinglin, Li, Zhenglong, Huang, Lining, Zhong, Xiangyu, Sun, Xueying, Wang, Zhidong, Cui, Yunfu

“…Akirin2 is a key regulator of embryonic development and the innate immunity response. However, this regulator’s role in tumorigenesis especially in…”
Get full text

Utilization of 3D printing technology in hepatopancreatobiliary surgery by Shi, Wujiang, Wang, Jiangang, Gao, Jianjun, Zou, Xinlei, Dong, Qingfu, Huang, Ziyue, Sheng, Jialin, Guan, Canghai, Xu, Yi, Cui, Yunfu, Zhong, Xiangyu

“…The technology of three-dimensional (3D) printing emerged in the late 1970s and has since undergone considerable development to find numerous applications in…”
Get full text

Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p by Li, Jinglin, Guan, Canghai, Hu, Zengtao, Liu, Lang, Su, Zhilei, Kang, Pengcheng, Jiang, Xingming, Cui, Yunfu

“…Cholangiocarcinoma (CCA) is one of the most aggressive and lethal malignancies. Long noncoding RNAs (lncRNAs) are being found to play crucial roles in CCA…”
Get full text

MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma by Ding, Chao, Yu, Huiming, Shi, Chenlei, Shi, Tiefeng, Qin, Huadong, Cui, Yunfu

“…Thyroid cancer keeps rapidly increasing worldwide and the most frequent type is papillary thyroid carcinoma (PTC). MicroRNAs (miRNAs) are proved dysregulated…”
Get full text

Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma by Liu, Tong, Meng, Guorui, Ma, Shihui, You, Junqi, Yu, Liang, He, Risheng, Zhao, Xudong, Cui, Yunfu

“…Among primary liver cancers, hepatocellular carcinoma is the most common pathological type. Its onset is insidious, and most patients have no obvious…”
Get full text

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis by Wang, Hao, Yu, Yang, Jiang, Zheng, Cao, Wen-Ming, Wang, Zhenyu, Dou, Jun, Zhao, Yanling, Cui, Yunfu, Zhang, Hong

“…Doxorubicin (Dox), one of the most effective chemotherapy drug for cancer treatment, is limited by its severe side effects and chemoresistance. Dox induces DNA…”
Get full text

Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value by He, Risheng, Wang, Zhongrui, Shi, Wenguang, Yu, Liang, Xia, Haoming, Huang, Ziyue, Liu, Shuqiang, Zhao, Xudong, Xu, Yi, Yam, Judy Wai Ping, Cui, Yunfu

“…Hepatocellular carcinoma (HCC) has become a challenging disease in the world today. Due to the limitations on the current diagnosis and treatment as well as…”
Get full text

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma by Xia, Haoming, Huang, Ziyue, Wang, Zhensheng, Liu, Shuqiang, Zhao, Xudong, You, Junqi, Xu, Yi, Yam, Judy Wai Ping, Cui, Yunfu

“…Glucose, the central macronutrient, releases energy as ATP through carbon bond oxidation and supports various physiological functions of living organisms…”
Get full text

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma by You, Junqi, Xia, Haoming, Huang, Ziyue, He, Risheng, Zhao, Xudong, Chen, Jiali, Liu, Sidi, Xu, Yi, Cui, Yunfu

“…Hepatocellular carcinoma (HCC) is a highly malignant tumor that carries a significant risk of morbidity and mortality. This type of cancer is prevalent in Asia…”
Get full text